KLSC Commends the Passage of key PBM reforms by Congress

The Kentucky Life Sciences Council applauds the House and Senate for passing long‑overdue pharmacy benefit manager (PBM) reforms, an important step toward curbing the opaque and anticompetitive practices of healthcare middlemen whose profit‑driven models have burdened patients, employers, and taxpayers for far too long. 

The legislation takes meaningful aim at reducing out‑of‑pocket costs for American families by dismantling incentives that encourage PBMs to steer patients toward higher‑priced medications to maximize profits. Importantly, it requires PBMs to pass through all rebates, fees, and discounts to Medicare Part D plan sponsors, ensuring employers receive savings to help lower premiums and patients pay a fairer price for prescription drugs. The bill also establishes strong transparency and reporting requirements that bring long‑needed accountability to PBM operations. 

These reforms reflect years of bipartisan work to address PBM practices that distort markets and drive-up costs for patients across the country. With Congressional passage now secured, KLSC urges President Trump to sign the spending package into law, delivering real, measurable relief for patients and advancing a more transparent and affordable prescription drug marketplace. 

Previous
Previous

OpEd: Keep American biopharma innovation American — fix what’s actually broken in drug pricing

Next
Next

KLSC released the following statement in support of the inclusion of critical PBM reforms in the Consolidated Appropriations Act, 2026: